Oppenheimer & CO Inc Pulse Biosciences, Inc. Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 17,850 shares of PLSE stock, worth $390,022. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,850Holding current value
$390,022% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PLSE
# of Institutions
78Shares Held
5.41MCall Options Held
139KPut Options Held
84.2K-
Black Rock Inc. New York, NY1.15MShares$25.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$21.8 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC786KShares$17.2 Million0.0% of portfolio
-
State Street Corp Boston, MA461KShares$10.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA457KShares$9.99 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $811M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...